companies / kamautx-com
Generated UTC · publication cutoff 2026-11-09
Insufficient cited evidence for a two-sentence summary.
Kamau Therapeutics was listed in Khosla Ventures's portfolio, recorded 2026-09-27.
verified=2026-05-23 json
| total_raised | 5,000,0005.0M | ○ |
|---|---|---|
| founded | 2023 | |
| hq | San Francisco, US | |
| industry | unknown | |
| stage | series-a |
Gene-correction therapeutics targeting sickle cell and genetic diseases
No cited completed company acquisition recorded.
Dated disclosures. Customer relationships and classifications are historical; ARR is separate from revenue.
No cited disclosure recorded: named customer, disclosed revenue, ARR, count, B2B / B2C, sector, go-to-market.
No cited valuation with an explicit basis is recorded.
Historical post-money / actual annual or stated TTM revenue. Same currency; economic valuation date within 90 days of revenue period end, inclusive. No FX, ARR, annualized revenue, estimates or projections. Conflicts and ambiguous ties are withheld.
No qualifying pair recorded.
| date | type | amount | lead | src |
|---|---|---|---|---|
| 2025-05-01 | series-a | 5,000,0005.0M | null | ○ |
| investor | src |
|---|---|
| Khosla Ventures | ○ |
Cloudflare, WordPress 6.9.4, reCAPTCHA, Flywheel 5.1.0, jQuery Migrate 3.4.1, Elementor 4.0.8, parallax.js 1.0, particles.js, Python, PHP, MySQL, jquery 3.7.1
| fact | status | src |
|---|---|---|
| Series A, $5.0M | attributed | ○ |
| Investor Khosla Ventures | sourced | WEB |
| existence | self-reported | WEB |
| description | self-reported | WEB |
| date | fact | change | src |
|---|---|---|---|
| 2026-09-27latest_round: series-a, $5.0M, 2025-05-01, lead: khosla → series-a, $5.0M, 2025-05-01, lead: null, ○ 2026-05-23 | latest_round | series-a, $5.0M, 2025-05-01, lead: khosla → series-a, $5.0M, 2025-05-01, lead: null | ○ 2026-05-23 |
| 2026-09-27provenance_investor_khosla: unknown → sourced, WEB 2026-09-27 | provenance_investor_khosla | unknown → sourced | WEB 2026-09-27 |
Records begin 2026-09-24. all_changes